
    
      The study is aimed at collecting preliminary safety and efficacy data related to the use of
      Drug Eluting Balloon (DEB) technology for the treatment of symptomatic Superficial Femoral
      Artery (SFA) ischemic vascular disease in patients presenting with long lesions.

      The present clinical evaluation is intended as a prospective observational data collection of
      patient treatment in full accordance with institution standard practice and utilizing an
      approved (CE marked) DEB currently available on the market.
    
  